Functional role of transporter Slc4a11 (BTR1/NaBC1) in the cornea
转运蛋白 Slc4a11 (BTR1/NaBC1) 在角膜中的功能作用
基本信息
- 批准号:8243356
- 负责人:
- 金额:$ 23.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-01 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibodiesApoptosisAqueous HumorBicarbonatesBilateralBoratesBoronCarrier ProteinsCattleCell LineCellsClinical assessmentsConfocal MicroscopyCorneaCorneal EndotheliumCorneal StromaCorneal dystrophyCoupledDataDiffuseEdemaEndoplasmic ReticulumEndothelial CellsExhibitsFaceFamilyFuchs&apos Endothelial DystrophyFunctional disorderGenesGeneticGoalsGuidelinesHearingHereditary DiseaseHumanHydration statusImmunohistochemistryIndividualInheritedIon TransportIonsKnock-in MouseKnockout MiceKnowledgeLabelLinkLiquid substanceLocationMaintenanceMass Spectrum AnalysisMeasurementMeasuresMediatingMicroelectrodesMicroscopeMolecularMonitorMusMutationPhenotypePhysiologicalPlasmaPlayPoint MutationPositioning AttributeProcessProtein FamilyProteinsPublishingReportingRoleSymptomsSyndromeTransgenic MiceTransgenic OrganismsVisionXenopus oocytealkalinityapical membraneaqueousbasebasolateral membraneextracellularfascinatemanmembermouse modelmutantoverexpressionresearch clinical testingresearch studysolute
项目摘要
DESCRIPTION (provided by applicant): Congenital hereditary endothelial dystrophy (CHED) causes impaired vision resulting from opacification of the cornea. The recessive form of CHED (CHED2) as well as some types of Fuch's endothelial dystrophy and Harboyan syndrome were recently shown to be associated with mutations in the SLC4A11 gene that encodes BTR1/NaBC1, a member of the bicarbonate transporter family. The function and subcellular location of this protein in cornea are unknown, and there is currently no adequate animal model for the study of CHED caused by SLC4A11 mutations. The goals of the proposed experiments are to determine the molecular function of SLC4A11 and its localization in the cornea, and to generate a mouse model for CHED2. The available functional information suggests that SLC4A11 transports Na+ and borate [B(OH)4- ], although no boron transport experiments with this protein have been performed. Specific Aim 1A is to use HEK293 cells and a corneal endothelial cell line, with mass-spectrometry, to determine whether mammalian (mouse, human) SLC4A11 cotransports Na+ and boron. Specific Aim 1B is to use Xenopus oocytes, with ion-selective microelectrodes, to determine whether SLC4A11 cotransports Na+ and HCO3-. In Specific Aim 2 we will perform immunohistochemistry to determine whether Slc4a11 is located in the basolateral or apical membrane of the mouse corneal endothelium. In Specific Aim 3 we will generate and evaluate the phenotype of a mouse model of CHED2 prepared by introducing, to mouse Slc4a11, a point mutation (in the position of human R755Q) that is known to cause CHED2 in humans.
PUBLIC HEALTH RELEVANCE: Maintenance of transparency of the cornea is essential for good vision. A variety of conditions can cause the cornea to become cloudy, including an inherited condition known as congenital hereditary endothelial dystrophy (CHED). Some forms of CHED are a result of mutations in a transport protein known as SLC4A11, the function of which has not been well established. The goals of this project are to determine the function of SLC4A11 and to establish a mouse model of CHED.
描述(由申请人提供):先天性遗传性内皮营养不良(CHED)会因角膜浑浊而导致视力受损。最近显示,隐性形式的 CHED (CHED2) 以及某些类型的 Fuch 内皮营养不良和 Harboyan 综合征与编码 BTR1/NaBC1(碳酸氢盐转运蛋白家族成员)的 SLC4A11 基因突变有关。该蛋白在角膜中的功能和亚细胞位置尚不清楚,目前还没有足够的动物模型来研究 SLC4A11 突变引起的 CHED。拟议实验的目标是确定 SLC4A11 的分子功能及其在角膜中的定位,并生成 CHED2 的小鼠模型。现有的功能信息表明,SLC4A11 转运 Na+ 和硼酸盐 [B(OH)4- ],尽管尚未对该蛋白进行硼转运实验。具体目标 1A 是使用 HEK293 细胞和角膜内皮细胞系,通过质谱分析确定哺乳动物(小鼠、人)SLC4A11 是否共同转运 Na+ 和硼。具体目标 1B 是使用爪蟾卵母细胞和离子选择性微电极来确定 SLC4A11 是否共同转运 Na+ 和 HCO3-。在具体目标 2 中,我们将进行免疫组织化学以确定 Slc4a11 是否位于小鼠角膜内皮的基底外侧膜或顶膜中。在具体目标 3 中,我们将生成并评估 CHED2 小鼠模型的表型,该模型是通过向小鼠 Slc4a11 引入已知会在人类中引起 CHED2 的点突变(在人 R755Q 的位置)而制备的。
公众健康相关性:保持角膜透明度对于良好视力至关重要。有多种情况会导致角膜变得浑浊,其中包括一种称为先天性遗传性内皮营养不良 (CHED) 的遗传性疾病。某些形式的 CHED 是一种名为 SLC4A11 的转运蛋白突变的结果,该蛋白的功能尚未明确。该项目的目标是确定SLC4A11的功能并建立CHED小鼠模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL L JENNINGS其他文献
MICHAEL L JENNINGS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL L JENNINGS', 18)}}的其他基金
Functional role of transporter Slc4a11 (BTR1/NaBC1) in the cornea
转运蛋白 Slc4a11 (BTR1/NaBC1) 在角膜中的功能作用
- 批准号:
8389867 - 财政年份:2011
- 资助金额:
$ 23.66万 - 项目类别:
ERYTHROCYTE POTASSIUM TRANSPORT AND VOLUME REGULATION
红细胞钾转运和容量调节
- 批准号:
2218479 - 财政年份:1995
- 资助金额:
$ 23.66万 - 项目类别:
ERYTHROCYTE POTASSIUM TRANSPORT AND VOLUME REGULATION
红细胞钾转运和容量调节
- 批准号:
3353165 - 财政年份:1987
- 资助金额:
$ 23.66万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE TRANSPORT PROTEINS
红细胞转运蛋白的生物化学研究
- 批准号:
2174824 - 财政年份:1987
- 资助金额:
$ 23.66万 - 项目类别:
ERYTHROCYTE POTASSIUM TRANSPORT AND VOLUME REGULATION
红细胞钾转运和容量调节
- 批准号:
2218478 - 财政年份:1987
- 资助金额:
$ 23.66万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE ANION TRANSPORT
红细胞阴离子转运的生物化学研究
- 批准号:
3274297 - 财政年份:1987
- 资助金额:
$ 23.66万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE ANION EXCHANGE
红细胞阴离子交换的生物化学研究
- 批准号:
6363218 - 财政年份:1987
- 资助金额:
$ 23.66万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE TRANSPORT PROTEINS
红细胞转运蛋白的生物化学研究
- 批准号:
2174825 - 财政年份:1987
- 资助金额:
$ 23.66万 - 项目类别:
BIOCHEMICAL STUDIES OF ERYTHROCYTE TRANSPORT PROTEINS
红细胞转运蛋白的生物化学研究
- 批准号:
2174823 - 财政年份:1987
- 资助金额:
$ 23.66万 - 项目类别:
相似国自然基金
分泌IL-6纳米抗体的重组枯草芽孢杆菌通过CXCL10/CXCR3轴介导CD4+效应T细胞凋亡减轻IBD肠道炎症的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗CD4自身抗体介导CD4+T细胞凋亡在艾滋病免疫无应答患者中的机制及治疗作用
- 批准号:
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
TNFR2抗体通过抑制CD8+T细胞凋亡进而促进抗肿瘤免疫的机制研究
- 批准号:81902918
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
凋亡细胞诱导的多反应性自然抗体介导大鼠移植肾排斥反应及损伤的机制
- 批准号:81873873
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
利用CRISPR/Cas9双基因精准编辑和强化CHO抗体表达体系研究
- 批准号:31670944
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Dual-payload antibody-drug conjugate for chemo-immunotherapy of triple-negative breast cancers
用于三阴性乳腺癌化学免疫治疗的双有效负载抗体-药物偶联物
- 批准号:
10711488 - 财政年份:2023
- 资助金额:
$ 23.66万 - 项目类别:
An IGF-1R-targeting peptide drug conjugate for targeted treatment of atypical teratoid/rhabdoid tumors
用于靶向治疗非典型畸胎瘤/横纹肌样瘤的 IGF-1R 靶向肽药物缀合物
- 批准号:
10760549 - 财政年份:2023
- 资助金额:
$ 23.66万 - 项目类别:
Engineered DNA-particles to model immune events in systemic lupus erythematosus
工程 DNA 颗粒模拟系统性红斑狼疮的免疫事件
- 批准号:
10644574 - 财政年份:2023
- 资助金额:
$ 23.66万 - 项目类别:
Mechanisms of macrophage death co-dependent on M. tuberculosis and IFN-a,b receptor
结核分枝杆菌和 IFN-a、b 受体共同依赖的巨噬细胞死亡机制
- 批准号:
10725738 - 财政年份:2023
- 资助金额:
$ 23.66万 - 项目类别:
Molecular etiology of virus-induced sensorineural hearing loss
病毒引起的感音神经性听力损失的分子病因学
- 批准号:
10705840 - 财政年份:2022
- 资助金额:
$ 23.66万 - 项目类别: